Successful treatment of rheumatoid arthritis‐associated interstitial lung disease with filgotinib: A case report on janus kinase 1 inhibition

Abstract Filgotinib, a janus kinase 1 (JAK1) inhibitor, is used in the treatment of rheumatoid arthritis (RA). RA‐associated interstitial lung disease (RA‐ILD) is a severe RA complication with no established effective treatment. We report the case of a patient with RA‐ILD successfully treated with f...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Atsuhiko Sunaga, Takuya Inoue
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-09-01
Edice:	Respirology Case Reports
Témata:	filgotinib interstitial lung disease JAK inhibitor RA‐associated interstitial lung disease rheumatoid arthritis
On-line přístup:	https://doi.org/10.1002/rcr2.70023
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!